All posts by imreal

Labroots to Host 6th Annual Drug Discovery & Development Online Event, February 22, 2023


Drug Discovery & Development, February 22, 2023

Labroots, the leading scientific social networking website offering premier, interactive virtual events and webinars, is hosting its Drug Discovery & Development virtual event on February 22, 2023. The 6th annual free event in the Drug Discovery & Development Virtual Event Series, is a dynamic reputable forum bringing together thousands of innovative research scholars, clinicians and scientists across leading, medical, industry, and academic professions from around the world.

The one-day informative agenda will feature over fifteen educational and sponsored presentations featuring the latest scientific findings while showcasing distinguished speakers in the field including, a keynote delivery by Professor Kevin Pfleger, PhD, Director of Biomedical and Health Innovation at The University of Western Australia explaining how molecular pharmacology approaches can be used to profile potential drug candidates prior to preclinical development.

“My laboratory has spent the last 20 years developing a molecular pharmacology profiling platform that is able to monitor various facets of receptor binding, signalling and trafficking in live cells and in real-time,” said Professor Kevin Pfleger, Director of Biomedical and Health Innovation at The University of Western Australia and Head of Molecular Endocrinology and Pharmacology at the Harry Perkins Institute of Medical Research. “This has uncovered novel pharmacology that underpins drug development by Dimerix and RAGE Biotech, with Dimerix progressing well beyond preclinical development into Phase 3 clinical trials. I’m excited to highlight these capabilities through Labroots’ unique platform.”

Drug Discovery & Development 2023 promises to deliver on its commitment of bringing emerging topics to the forefront of the scientific community such as Improved Models in Drug Discovery and Preclinical Development, New Methods in PK/PD and Pharmacogenomics, and Biomarker Applications in Clinical Development.

These sessions (not limited to) will cover characterization of anti-HER2 antibodies using advanced flow cytometry and BLI label-free detection and get pipetting right – tips and tricks for accurate and reproducible results – both talks with live Q&A and sponsored by Sartorius; and using single B technology to develop lead antibody molecules on GPCR targets with live Q&A, sponsored by DIMA Biotech. Spanning the day, additional presentations on demand for immediate viewing when the event is live explore avoiding In Vivo study pitfalls, current use of GPCR pharmacogenomics in clinical practice, innovative biomarker spatial analysis for comprehensive tissue immunophenotyping, PDX/PDO models for precision cancer medicine beyond mutations naming just a few and much more, you won’t want to miss!

Produced on Labroots’ robust platform, this online event allows participants to connect seamlessly across desktop and mobile devices, delivering a one-stop complete educational experience. The interactive environment includes a lobby equipped with a leaderboard and gamification, an auditorium featuring live-streaming video webcasts with live attendee chats during scheduled presentations, an exhibit hall to interact with sponsors highlighting contributions in the field, a poster hall to explore data and engage in live chat conversations complete with a poster competition giving your research a competitive edge, and a networking lounge to encourage collaborations with colleagues. By participating, there is a potential to earn up to 1 P.A.C.E. Continuing Education credit per presentation for a maximum of 30 credits.

To register for the event, click here. Remember to use the hashtag #LRdrug to follow the conversation and connect with other members of the global Drug Discovery & Development community!

Follow @DrugDiscoveryLR on Twitter and @DrugDiscoveryandDevelopment on Facebook to connect with our specialist Drug Discovery & Development writers and stay up to date with the latest Trending News in Drug Discovery & Development. You can now also join our Drug Discovery, Development, & Therapeutics professional networking group on LinkedIn!

About Labroots

Labroots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, Labroots is a powerful advocate in amplifying global networks and communities. Founded in 2008, Labroots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, Labroots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events. Labroots offers more than ever with Chati, a flexible, highly scalable event platform that allows for the creation of unique, effective, and memorable virtual events.

Share article on social media or email:

Ngoc Bui-Tong promoted to newly-expanded position of Chief Health…


Santa Clara Family Health Plan (SCFHP) is proud to announce the promotion of Ngoc Bui-Tong – formerly Vice President, Strategies and Analytics – to the newly-expanded position of Chief Health Equity…

(PRWeb February 16, 2023)

Read the full story at https://www.prweb.com/releases/ngoc_bui_tong_promoted_to_newly_expanded_position_of_chief_health_equity_strategies_officer_at_santa_clara_family_health_plan/prweb19114670.htm

Providing Short Term Skin Barrier Protection May Help Prevent Atopic Dermatitis in Certain Infants


AAAAI Logo

Being able to prospectively ascertain a child’s FLG status at birth could allow targeted, time sensitive treatments just for those most at risk and conversely could prevent other children, at lower risk, from entering trails or having unnecessary treatment.

Early research being presented at the 2023 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) found that infants with specific mutations may benefit from the use of daily specialized emollient to reduce the risk of developing atopic dermatitis.

Loss-of-function (LOF) filaggrin (FLG)-mutations are known to be the strongest genetic risk factor for atopic dermatitis. Researchers recruited 321 newborns for a study, randomizing them 1:1 between an intervention group receiving emollient treatment during the first two months of life and a control group. “Knowing this genetic risk factor, we wanted to examine if using this treatment at the start of life could make a difference on the future development of atopic dermatitis,” said Jonathan O. Hourihane, MD, FAAAAI, primary author of the study.

A total 257 infants with genotyping completed the study, with 119 in the intervention group and 138 in the control group. The 12-month cumulative incidence of atopic dermatitis was 46% in the control group compared to 33% in the intervention group.

Of all study participants, 17.4% were LOF-FLG mutation carriers, and they had higher atopic dermatitis prevalence in the control group of 56% at six months and 59% at 12 months, compared to 32% at six months and 34% at 12 months in WT-FLG. In the intervention group, LOF-FLG babies experienced atopic dermatitis rates similar to those of WT-FLG infants. “We did not know the children’s’ genotype until after the study finished. Being able to prospectively ascertain a child’s FLG status at birth could allow targeted, time sensitive treatments just for those most at risk and conversely could prevent other children, at lower risk, from entering trails or having unnecessary treatment,” said Dr. Hourihane.

The use of daily, specialized emollient in the first two months of an infant’s life may be beneficial for LOF FLG-mutation carriers, and could reduce their likelihood of developing atopic dermatitis in the future. Genetic testing for this mutation could help healthcare professionals determine which patients could benefit most from this preventative strategy.

Visit aaaai.org to learn more about atopic dermatitis. Research presented at the AAAAI Annual Meeting, February 24-27 in San Antonio, Texas, is published in an online supplement to The Journal of Allergy and Clinical Immunology.

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. The AAAAI is the go-to resource for patients living with allergies, asthma and immune deficiency disorders. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

Share article on social media or email:

IntelliGenesis LLC Advances Cybersecurity with New Products, Expands Collaboration with NVIDIA


IntelliGenesis LLC releases new products, IG Labs now an AI/ML Center of Excellence

“I am so proud of IntelliGenesis and our products which encapsulate our 15+ years of Cyber and AI expertise in a self-contained, repeatable way to readily provide these bleeding-edge technologies and methodologies to enhance missions worldwide.” – Angie Lienert, President & CEO, IntelliGenesis LLC

IntelliGenesis LLC Advances Cybersecurity with New Products, Expands Collaboration with NVIDIAArtificial Intelligence (AI) is no longer the future — it is advancing cybersecurity today.

IntelliGenesis LLC’s IG Labs Division today announced the launch of its first two products, the first of which includes its Modular Advanced Cyber Environment (M.A.C.E) System. The M.A.C.E system harnesses NVIDIA® technology to provide AI-enabled Cyber-Physical Security training and development by replacing its current compute source with the NVIDIA Jetson Orin™ edge AI platform.

The company also announced today that its IG Labs Division is now an AI/ML Center of Excellence, powered by NVIDIA.IG Labs has over the last year expanded its collaboration with NVIDIA, which allows IG Labs developers and AI engineers to bolster the development and deployment of its capabilities into commercial and government customers, businesses, and missions. As a result, IG Labs also released its second product, an AI-enabled cybersecurity product, CyberSpan™, to be followed by Neural Nexus™ in the Spring of 2023. CyberSpan™ is an AI-enabled cybersecurity product that provides fundamental cyber protection for small-to-medium sized Defense Industrial Base (DIB) companies’ networks deploying machine learning (ML) and deep learning (DL) models. The CyberSpan™ models are developed and trained on the NVIDIA DGX A100 system utilizing supervised and unsupervised learning models mapped to MITRE ATT&CK Tactics, Techniques, and Procedures (TTPs) to identify previously unidentifiable anomalous activity.

IntelliGenesis LLC is a Columbia, Maryland-based Veteran- and Woman-owned small business, primarily known for its analytics development, AI/ML, and training services in support of DoD and Intelligence Community customers since 2007.IG Labs opened for innovation in October 2021 to invest internally into expanding its AI/ML services and developing cutting-edge, AI-enhanced capabilities for customers. A benefit of the AI/ML Center of Excellence has been guiding partners through the art of the possible with AI, ML and DL to take on opportunities like developing products and delivering an AI-enabled cybersecurity platform that enables users with no prior experience to operate defensively in adversarial environments.

IntelliGenesis’ release of Neural Nexus™ will redefine how companies acquire, deploy, and benefit from a Machine-Learning-as-a-Service (MLaaS) capability. To learn more about how IG Labs’ AI/ML Center of Excellence is utilizing NVIDIA capabilities, attend NVIDIA GTC, a global AI conference, on Wednesday, March 22, at 10:00am ET, where our Chief Technologist, Stephen “Scribbs” Scarbrough, will be on a panel to discuss how industry experts are accelerating cybersecurity with AI. During GTC, IntelliGenesis will also unveil more details about Neural Nexus™ and how customers can benefit from it.

IG Labs partners with innovation labs across the country and will begin assisting in the education and training of government and commercial customers to bring tailored AI/ML/DL training featuring NVIDIA Deep Learning Institute (DLI) courses. Educating the government and commercial workforce is essential to the adoption of these groundbreaking capabilities in AI/ML/DL, and will help shape tomorrow and protect our networks.

The IG Labs Division AI/ML Center of Excellence welcomes visitors, partners and those interested in AI to contact us at info@intelligenesisllc.com.

Share article on social media or email:

Aeroflow Healthcare Appoints Lauren Bennett As New Vice President Of Aeroflow Sleep


Lauren Bennett

Lauren Bennett

“I’m honored to be a part of a company that is working diligently to improve the lives of individuals and provide them with the tools to receive the necessary medical supplies through insurance, especially as recalls and shortages have greatly impacted access to care.”

Aeroflow Healthcare, a nationwide provider of durable medical equipment through insurance, is proud to announce it has named Lauren Bennett as Vice President to lead the nation’s fastest growing solution for getting PAP supplies, Aeroflow Sleep.

A member of Aeroflow Healthcare for almost a decade, Bennett began her journey in the company’s Mom & Baby division as one of the first Inside Sales Representatives where she quickly moved into management, and played a pivotal role in growing the Mom & Baby division as a leader in the breast pumps industry. Since 2019, Bennett has been working in the Sleep Division after being promoted to Director of Sales Operations.

Over the last three years, the sleep industry has been completely upended by a prolonged CPAP recall and machine shortage, however with Bennett’s consistent leadership, Aeroflow Sleep emerged as one of the preeminent CPAP providers in the country. As the new Vice President, Bennett will be responsible for driving Aeroflow Sleep’s success in new markets and will ensure increased access to CPAP supplies through insurance for Aeroflow’s customers.

“I’m extremely excited to continue growing with Aeroflow Sleep in this new position, and am looking forward to leading our strong, hardworking team” says Lauren Bennett. “I’m honored to be a part of a company that is working diligently to improve the lives of individuals and provide them with the tools to receive the necessary medical supplies through insurance, especially as recalls and shortages have greatly impacted access to care.”

Share article on social media or email:

Marietta, Georgia, Family Dental Clinic, Marietta Dental Professionals, Selected as a 2023 Top Patient Rated Dentist


News Image

“It is such an honor to be recognized once again by Find Local Doctors. We are so proud to provide excellence in dentistry for our patients,” says Dr. Dipesh Patel.

At Marietta Dental Professionals, the talented staff members are passionate about creating dream smiles in a responsible and conservative way. The clinic, conveniently located at 2551 Roswell Rd., Building 100 in Marietta, GA, is a state-of-the-art family dental practice. Offering the best, Marietta Dental Professionals was established with the mission of providing high-quality, modern dentistry in a comfortable, stress-free environment. Find Local Doctors has given this prestigious award to Marietta Dental Professionals as a result of the outstanding patient reviews and five-star ratings they have received from patients across multiple sources. Find Local Doctors is a trusted online directory that helps consumers easily locate reputable dentists and physicians in their area.

At Marietta Dental Professionals, they go to great lengths to ensure they are able to address all facets of a patient’s smile through all stages of life. Patients can receive the dental care they need and deserve, ranging from preventative dental cleanings for kids to full-service dental implants for aging adults. The dentists at this clinic value the importance of building a relationship with the patients they treat and bring unrivaled skill and experience to a wide variety of dental procedures, including those in general, pediatric, cosmetic and restorative dentistry. The skilled dental team is qualified to offer a number of specialized treatments, such as smile makeovers, clear orthodontics, emergency dental care and more. To guarantee superior service, Marietta Dental Professionals has adopted the most advanced dental technology in the industry, including 3D imaging, intraoral scanners and superior in-office teeth whitening systems.

“It is such an honor to be recognized once again by Find Local Doctors. We are so proud to provide excellence in dentistry for our patients,” says Dr. Dipesh Patel.

More about Marietta Dental Professionals:

Marietta Dental Professionals provides cutting-edge dental technology and relaxing amenities, keeping patients comfortable at every step in the treatment process. Dr. Dipesh Patel completed his undergraduate studies with honors at the University of Georgia before earning his doctorate from Nova Southeastern University College of Dental Medicine in 2012. To further solidify his education in dentistry, he has dedicated countless hours to completing continuing education courses to keep up with modern dentistry. Dr. Lina Al-Chaar received her dental doctorate from the University of Illinois at Chicago College of Dentistry. She was honored with multiple awards during her time at the dental school, including recognition for teaching dentistry, excellence in diagnosis and treatment planning, and in advocating for health literacy. Dr. Arti Patel completed her undergraduate studies at the University of Georgia and earned her doctorate from the Dental College of Georgia. Dr. Arti is a primary dental care provider for patients of all ages. She specializes in diagnosing, preventing, and treating diseases and conditions associated with overall dental and oral health. For more information about the services offered at Marietta Dental Professionals, please visit http://www.mariettadentalpros.com or call (770) 514-5055.

Share article on social media or email:

SafetyStratus Opens Doors for Discussion About Field Research Safety


“We have experienced first-hand that the safety industry is built on collective ideas and input. Knowing that our work helps make a way for others to share knowledge is so rewarding.” -Wendy Kern-Usrey

SafetyStratus, the user-friendly enterprise EH&S software platform, will once again be sponsoring a professional development event for the Campus Safety, Health, and Environmental Management Association (CSHEMA.) The 2023 CSHEMA Spring Symposium is a two-day summit for EH&S professionals in higher education to meet and discuss best practices and experiences in the realms of academic research and safety. This year’s event will take place February 27 – 28 at the University of California in Santa Barbara, California, and will offer over 20 educational opportunities that focus on the theme of safety when conducting field research.

The CSHEMA Symposia open doors to advance various topics of discussion for EH&S professionals in higher education. “We always look forward to CSHEMA events,” says the Director of Sales for SafetyStratus, Wendy Kern-Usrey. “We have experienced first-hand that the safety industry is built on collective ideas and input. Knowing that our work helps make a way for others to share knowledge is so rewarding.” Over 20 guest speakers will participate in this “knowledge sharing” through table talks, panel discussions, and presentations. In between these professional development sessions, Symposium attendees will have the chance to network, view exhibitions, and discuss the latest methodologies and product innovations for promoting and improving safety.

Safetystratus was incubated at Cornell University. Though, as a company, SafetyStratus now has user community partnerships in a wide range of industries, it is the desire of everyone on the team to always be a part of supporting efforts within higher education to protect researchers and make campuses safer. With the 2023 Spring Symposia, SafetyStratus will continue its legacy of sponsoring CSHEMA events in the spirit of elevating safety at institutions across the country.

The University of California at Santa Barbara has a campus overlooking the Pacific Ocean. The natural beauty of the setting for the 2023 Spring Symposium is complimented by its famous architecture. Conference attendees are encouraged to partake of the campus’ many walking and bicycle paths, as well as visit the special networking reception that SafetyStratus will be hosting at the end of the first day to bring colleagues together in an engaging atmosphere.

To learn more about the presentations and schedule for the CSHEMA 2023 Spring Symposium, visit: https://www.cshema.org/spring-symposium-2023

To hear about more upcoming EH&S events, visit the EHS Buzz page.

About SafetyStratus

==================

SafetyStratus is designed by EH&S professionals for EH&S professionals. Our multi-level technology platform brings user-friendly, practical innovation to Environmental, Health, and Safety Management in Academia, Healthcare, Construction, and Manufacturing. Our aim is to always be learning. We save lives and the environment by successfully integrating knowledgeable people, sustainable processes, and transformative technology. SafetyStratus has headquarters located in Plano, TX with an employee base of industry experts and leaders, spanning the globe.

For more information visit http://www.safetystratus.com or LinkedIn, Twitter, and Facebook.

Share article on social media or email:



Catalent Expert to Discuss Supply Strategies at Upcoming Clinical Outsourcing Group Conference


Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced that its Global Director of Clinical Supply Management, Stephanie Graham, is to speak at the upcoming Clinical Outsourcing Group (COG) Conference, to be held at the Royal Garden Hotel, London, U.K., on Feb. 21-22, 2023.

Ms. Graham’s presentation, on Feb. 22 at 10:30 a.m., is entitled “Proactive Strategies to Evaluate and Mitigate Clinical Supply Risk” focuses on strategies that build understanding of risk assessment within clinical supply planning, and how studies’ protocol requirements, drug characteristics, packaging specifications, and patient compliance concerns, must be identified and addressed in order to mitigate risk for successful clinical supply outcomes.

In her role at Catalent, Stephanie Graham has responsibility for clinical supply within the European, Asia-Pacific and North American regions. She has over 17 years of experience in the industry, with specific focus on forecasting, packaging and distribution of clinical materials. Prior to joining Catalent, she worked at Shire Pharmaceuticals, Takeda and Fisher Clinical Services, and before working in the pharmaceutical industry, spent 13 years in international shipping. She is a member of the Global Clinical Supplies Group (GCSG) and Clinical Supplies Discussion Group (CSDG).

With a network spanning the U.S., U.K., Germany, Singapore, Japan, and China, plus more than 50 additional global depots, Catalent’s clinical supply services can handle a broad range of international compliance and distribution requirements to support global clinical trials.

To find out more information about this event, visit http://www.catalent.com/events/cog-uk-2023

About Catalent Clinical Supply Services

Catalent solves today’s clinical trial challenges and develops innovative solutions for the future. The company’s commitment to quality and service excellence is evident in its flexible solutions, modern global facilities, and over 25 years’ experience of reliably supplying thousands of studies of all sizes and complexities, all around the world.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Renee Sexton Joins Healthcare RCM Data, Advisory, & Services Company, Viewgol, as Director, Community Health Center Solutions


Viewgol Logo

Using enterprise-grade technology, a robust business intelligence team, and RCM experts, Viewgol empowers healthcare organizations to create RCM Heroes.

“She brings deep industry knowledge into every discussion, which elevates Viewgol’s ability to serve CHCs better.” – Kristen Closson, COO of Viewgol

Viewgol, a healthcare RCM data, advisory, and services company, welcomes Renee Sexton to the team as Director, Community Health Center Solutions. Sexton has extensive experience in the healthcare industry, starting as a medical assistant before becoming a practice administrator. Later, she served as a solution architect at NextGen RCM and ModMed, accumulating more than 14 years of experience working closely with Community Health Centers (CHCs).

CHCs are non-profit organizations that receive federal funding to provide comprehensive primary care and preventive health services to underserved communities, irrespective of patients’ ability to pay or insurance status.

To maintain their funding and continue to provide quality care to their patients, CHCs must ensure they comply with strict reporting requirements from the Health Resources and Services Administration, Centers for Medicare and Medicaid Services, state health departments, and the Bureau of Primary Health Care.

“Viewgol shares many core values with RHCs, FQHCs, and Tribal Health organizations that serve indigenous communities,” said Sexton. “I am drawn to and excited to join Viewgol because we share a vision to care for patients through caring for the financial health of healthcare organizations. The talent level at Viewgol is unmatched. I’m thrilled to join this high-caliber team where I can learn and grow.”

As a trusted advisor to its clients at the executive and operational levels, Viewgol provides services to healthcare organizations of varying sizes across multiple specialties. By partnering with Viewgol, healthcare organizations can discover systemic RCM issues, identify opportunities, access relevant data, and implement solutions using enterprise-grade technology, a robust business intelligence team, and RCM experts.

Sexton will work with Viewgol’s CHC clients to maintain good standing with the federal, state, and local agencies. As healthcare financial systems grow in complexity, Viewgol Analytics, the company’s proprietary RCM software, brings key metrics to the surface that are inaccessible in most healthcare PM systems.

“Viewgol impacts our clients so they are financially successful and can fully serve their communities. Renee will serve countless patients by helping CHCs maximize their various funding sources in hundreds of communities across the US,” said Reid Storch, CRO for Viewgol.

“Renee is often the smartest person in the room and is always a great resource for her clients. It is fantastic to work alongside her once again,” said Kristen Closson, COO of Viewgol. “She brings deep industry knowledge into every discussion, which elevates Viewgol’s ability to serve CHCs better.”

Viewgol provides customized RCM solutions to meet the needs of each client, from the small practice that requires best-in-class data to the nationwide healthcare organization that needs complete RCM services. If you want to learn more about Viewgol and its products and services, please visit the official website Viewgol.com.

About Viewgol

Viewgol specializes in healthcare revenue cycle management as an RCM data, advisory, and services company. Its goal is to create RCM Heroes by making RCM data accessible, understandable, and applicable. Viewgol caters to healthcare organizations of all sizes and specialties. Viewgol’s primary products, Analytics, Engage, and Comprehensive, solve RCM problems and identify actionable opportunities. Viewgol’s business intelligence team detects issues and provides custom solutions by examining every aspect of an organization’s RCM process. To learn more, please visit Viewgol.com.

Share article on social media or email:

Cogent Growth Partners Advises MDcentric on its Sale to Medicus IT


News Image

M&A activity in the healthcare sector has been fast and furious for the past few years as HIT MSPs consolidated.

Cogent Growth Partners (CGP), the leading buy-side advisory firm for IT Services mergers and acquisitions, today announced that it guided MDcentric Technologies through its sale to Medicus IT, one of the country’s leading providers of managed IT services to healthcare providers and organizations.

“M&A activity in the healthcare sector has been fast and furious for the past few years as HIT MSPs consolidated,” said Rick Murphy, CEO and Managing Partner, Cogent Growth Partners. “Consulting for the sell-side, while not our core business, is also what we do every day during our buy-side activities, so helping sellers occasionally allows us to leverage our abilities and help both sides get through the confirmatory due diligence and contract phases in a happy state, which is critical to M&A success.”

MDcentric Technologies, based in Charlotte, North Carolina, specializes in providing co-managed IT services, cybersecurity, VoIP, cloud computing and device management services to the ambulatory healthcare market. These services not only improve the efficiency of care, they create an improved digital experience for their customer’s patients across the Carolinas.

“Cogent’s proprietary processes helped us navigate through the complexities of due diligence and all of the myriad contracts and schedules with ease,” said Clint Harris, CEO, MDcentric. “With Cogent at our side, we were able to stay focused on the ‘why’ behind the deal and the overall opportunity, not just the numbers.”

For Alpharetta, Georgia-based Medicus IT, one of the country’s largest providers of managed IT services for the healthcare industry, acquiring MDcentric is the fifth time the company has chosen to supplement its organic growth with a merger. Medicus IT has specifically chosen to acquire providers of managed IT services that understand the compliance-heavy healthcare environment.

“As a serial acquirer, we are clear about what we are looking for: an MSP with deep technical and compliance experience in the highly regulated ambulatory healthcare environment,” said Chris Jann, CEO of Medicus IT. “Cogent has deep experience doing the work-product required to make IT deals happen through to closing, and their deep bench of talented M&A people have the experience we need to help us get these deals done. Those two factors made working with Cogent a natural for us.”

About MDcentric Technologies

Founded in 2002, MDcentric Technologies has amassed significant expertise in IT managed services, healthcare IT, EMR and PM, IT security, HIPPA compliance, IT consulting, IT networking, cloud hosting and VoIP telephony. MDcentric prides itself on ensuring that technology works seamlessly in the background, freeing healthcare professionals to focus on patient care.

About Medicus IT

Since 2004, Medicus IT has been providing managed services, IT professional services, IT security and compliance, cloud services, value-based care solutions and VoIP to health-related providers, institutions and organizations. Medicus IT’s mission is to better the healthcare industry experience for practices and patients, turning tech that’s a burden into systems and proactive solutions that make a real difference every day.

About Cogent Growth Partners

Cogent Growth Partners, the leading IT Services mergers and acquisitions advisory firm nationwide with more than 150 closed transactions since 2010, taps into the growth opportunities found in America’s IT businesses. Cogent accelerates the M&A process with a set of proprietary tools and processes that enable buyers and sellers to stay focused on running their respective businesses while they do the M&A work. Anyone who wants to know why Cogent is different, need look no further than their maxim: Providing Transaction Therapy™ to IT Business Owners since 2010. For more information, email info@cogentmergers.com, visit http://www.cogentmergers.com or call (678) 820-5288.

Share article on social media or email: